This article has been updated to include additional background information and Illumina's stock price.
 
NEW YORK (GenomeWeb News) – Illumina said today that it has reorganized its operating structure and divided the firm into two new divisions, the Life Sciences Business Unit and the Diagnostics Business Unit.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.